Introduction: Production of complex human recombinant proteins is an important issue in medical biotechnology. These proteins are mostly expressed in non-human mammalian host cells. This has some problems including non-human post-translational modifications, application of high-cost agents for inducing protein expression and low yields. Thus, it is necessary to use new expression systems to overcome the indicated challenges.
Methods: In this paper, we hypothesize the application of promoter regions of cancer genes, which have a high rate of transcription in human cancer cell lines, for designing new expression vectors.
Results: After designing, these vectors could be applied to produce complex hu-man recombinant proteins in the human cancer cell lines as production hosts.
Conclusion: Application of these expression vectors for the production of recombinant human proteins in the human cancer cell lines have some advantages including authentic post-translational modifications, proper-cost of commercialization, and high yields.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648915 | PMC |
http://dx.doi.org/10.5681/bi.2012.007 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!